How should I approach a patient with gestational diabetes mellitus (GDM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Approach to Gestational Diabetes Mellitus

Screen all pregnant women at 24-28 weeks of gestation using either a one-step 75-g OGTT or two-step approach with 50-g glucose challenge followed by 100-g OGTT, then manage with lifestyle modifications first, escalating to insulin if glycemic targets are not met within 1-2 weeks. 1, 2

Initial Risk Assessment and Early Screening

Perform diabetes risk assessment at the first prenatal visit. Women at very high risk require immediate screening using standard diagnostic criteria (not GDM criteria):

Very high-risk criteria requiring early screening:

  • Severe obesity
  • Prior GDM or delivery of large-for-gestational-age infant
  • Glycosuria
  • Polycystic ovary syndrome (PCOS)
  • Strong family history of type 2 diabetes
  • A1C ≥5.9% or fasting glucose ≥110 mg/dL 3, 1

Critical distinction: If early screening reveals diabetes by standard criteria (fasting glucose ≥126 mg/dL, A1C ≥6.5%, or 2-hour glucose ≥200 mg/dL), classify as diabetes complicating pregnancy (usually type 2), not GDM—this requires more intensive management. 1

Diagnostic Testing at 24-28 Weeks

If early screening is negative or not indicated, all women except those at low risk should undergo GDM testing at 24-28 weeks. The evidence supports two acceptable strategies, though they identify different populations:

One-Step Strategy (IADPSG Criteria)

Perform 75-g OGTT after 8-hour overnight fast with measurements at fasting, 1-hour, and 2-hour. Diagnose GDM if ANY ONE value meets or exceeds:

  • Fasting: ≥92 mg/dL (5.1 mmol/L)
  • 1-hour: ≥180 mg/dL (10.0 mmol/L)
  • 2-hour: ≥153 mg/dL (8.5 mmol/L) 1, 4, 2

Advantage: Identifies more women at risk for adverse outcomes and future diabetes (3.4-fold higher risk at 11 years), captures offspring at higher risk for obesity and metabolic dysfunction. 2, 4

Two-Step Strategy (Carpenter-Coustan Criteria)

Step 1: 50-g glucose load test (non-fasting), measure at 1 hour. If ≥130,135, or 140 mg/dL, proceed to Step 2.

Step 2: 100-g OGTT when fasting. Diagnose GDM if AT LEAST TWO values meet or exceed:

  • Fasting: ≥95 mg/dL (5.3 mmol/L)
  • 1-hour: ≥180 mg/dL (10.0 mmol/L)
  • 2-hour: ≥155 mg/dL (8.6 mmol/L)
  • 3-hour: ≥140 mg/dL (7.8 mmol/L) 1, 4, 1

Note: ACOG states one elevated value can diagnose GDM, though traditional criteria require two. 1, 4

Practical consideration: The one-step approach identifies 15-20% of pregnancies versus 5-6% with two-step, but follow-up data strongly supports identifying this larger group given their significantly elevated long-term risks. 2, 1, 4

Management Algorithm

Step 1: Lifestyle Modifications (First-Line for ALL)

Initiate immediately upon diagnosis:

Medical Nutrition Therapy:

  • Refer to registered dietitian nutritionist (RDN) familiar with GDM
  • Minimum 175 g carbohydrate daily (avoid excessive restriction)
  • Minimum 71 g protein, 28 g fiber
  • Emphasize low glycemic index carbohydrates, monounsaturated/polyunsaturated fats
  • Limit saturated fats, avoid trans fats
  • Distribute carbohydrates across meals to prevent postprandial spikes 5, 6

Physical Activity:

  • At least 150 minutes/week of moderate-intensity aerobic activity
  • Spread throughout the week
  • Can include aerobic, resistance, or combined exercise
  • Duration: 20-50 min/day, 2-7 days/week 5, 6

Expected outcome: 70-85% of women diagnosed by Carpenter-Coustan criteria achieve control with lifestyle alone; this percentage is higher with IADPSG criteria. 5, 6

Step 2: Glycemic Monitoring

Self-monitoring targets:

  • Fasting glucose: <95 mg/dL (5.3 mmol/L)
  • 1-hour postprandial: <140 mg/dL (7.8 mmol/L) OR
  • 2-hour postprandial: <120 mg/dL (6.7 mmol/L) 7, 6

Monitoring frequency: Check fasting and postprandial values daily, rotating meals to assess all eating occasions.

Step 3: Pharmacologic Therapy

Initiate if glycemic targets not met with lifestyle modifications within 1-2 weeks.

First-line: INSULIN 6

Insulin regimens:

  • Long-acting: NPH, detemir, or glargine (detemir has strongest safety data in pregnancy)
  • Rapid-acting: Lispro or aspart for postprandial control
  • Typical starting dose: 0.7-1.0 units/kg/day, divided between basal and prandial
  • Adjust based on glucose patterns 7, 5

Critical caveat: Insulin requirements typically plateau in late third trimester—a rapid decrease may indicate placental insufficiency requiring immediate evaluation. 5

Alternative agents (NOT first-line):

Metformin:

  • Crosses placenta with cord blood levels equal to or higher than maternal levels
  • Concern: MiG TOFU study showed 9-year-old offspring had higher weight, waist-to-height ratio, and waist circumference versus insulin-exposed offspring
  • Additional studies show increased childhood BMI and obesity risk
  • Use only if insulin unavailable or patient refuses 6

Glyburide:

  • Crosses placenta (cord levels 50-70% of maternal)
  • Associated with increased neonatal hypoglycemia and higher rates of macrosomia versus insulin
  • Not recommended 6

Bottom line: While metformin and glyburide may control glucose, long-term offspring safety concerns make insulin the clear first choice. 6

Fetal Surveillance and Delivery Planning

For medication-requiring GDM:

  • Begin fetal surveillance (non-stress tests, biophysical profiles) at 32 weeks
  • Assess for macrosomia (estimated fetal weight >4,000 g)
  • Delivery timing: 39 0/7 to 39 6/7 weeks for optimal outcomes 6, 8

For diet-controlled GDM:

  • Less intensive surveillance acceptable
  • Delivery timing: 39 0/7 to 40 6/7 weeks 6, 8

Cesarean delivery consideration: Discuss prelabor cesarean if estimated fetal weight >4,500 g due to shoulder dystocia risk. 8

Postpartum Management

Immediate postpartum (6-12 weeks):

  • Screen for persistent diabetes using 75-g OGTT with non-pregnant criteria
  • Do NOT use A1C at this visit (unreliable due to pregnancy-related changes) 9

Long-term follow-up:

  • Lifelong screening at least every 3 years for diabetes/prediabetes
  • Women with GDM have greatly increased subsequent diabetes risk
  • If prediabetes develops: intensive lifestyle interventions (5-10% weight loss, 150 min/week exercise) or metformin 3, 9

Risk reduction strategies:

  • Encourage breastfeeding (reduces future diabetes risk)
  • Maintain healthy weight
  • Continue physical activity
  • Preconception counseling before future pregnancies 9

Common Pitfalls to Avoid

  1. Using A1C for GDM diagnosis at 24-28 weeks—not validated for this purpose
  2. Using GDM criteria for early pregnancy screening—use standard diabetes criteria instead
  3. Delaying insulin when lifestyle fails—start within 1-2 weeks to prevent complications
  4. Choosing metformin as first-line—offspring data raise significant concerns
  5. Missing postpartum follow-up—50% of women with GDM develop diabetes within 10 years
  6. Ignoring declining insulin needs late in pregnancy—may signal placental insufficiency

References

7
Guideline

american association of clinical endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan-2022 update.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2022

Related Questions

What is the best approach for managing uncontrolled gestational diabetes mellitus (GDM) in pregnancy?
What is the appropriate management for a 37‑week‑gestation singleton with gestational diabetes mellitus and no prior prenatal care?
Why is tight glucose control crucial in gestational diabetes mellitus during pregnancy, and what are the recommended target levels and management strategies?
What are the key differences in managing Gestational Diabetes Mellitus (GDM) versus overt diabetes during pregnancy?
I am 32 weeks pregnant with a glucose tolerance test showing fasting 99 mg/dL, 1‑hour 210 mg/dL, 2‑hour 175 mg/dL, and 3‑hour 72 mg/dL; how should I manage gestational diabetes mellitus (GDM)?
What are the appropriate next steps in evaluation and management for a patient with a one‑year history of a large (~30 cm) abdominal mass extending to the left rib margin and lower right abdomen, presenting only with vague bloating?
Will a muscle relaxant help with a pinched nerve in the neck, a bulging disc in the back, and bursitis, given worsening leg pain?
What is the most appropriate medication for constipation in a healthy 15-year-old adolescent?
What history elements and examinations should be obtained when evaluating a new 62‑year‑old patient?
What short‑term opioid bridge (dose, frequency, and duration) should be prescribed for a patient with chronic cervical and lumbar pain, recent steroid injection, currently out of hydrocodone/acetaminophen 5 mg/325 mg, awaiting a transition‑of‑care appointment?
In a woman with lower right abdominal pain, unilateral foot paresthesia, and aversion to sitting, how does foot tingling modify the clinical suspicion for benign versus malignant causes of a lumbar region lump?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.